BCAS1 and multiple sclerosis: Bcas1 expression defines a population of early myelinating oligodendrocytes in multiple sclerosis lesions (43) and Bcas1-positive immature oligodendrocytes seem to be affected by α-synuclein–induced pathology in multiple system atrophy (44).